Targeting IGF1R pathway in cancer with microRNAs: How close are we?

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Head and neck cancers represent 30% of all cancers in India.
• Molecular drivers include overexpression of growth factors (IGF1-R, EGFR, VEGF-R) and cell cycle dysregulation.
• Insulin-like growth factor 1 receptor (IGF1-R) is a key target, but IGF1R-targeted agents face resistance and toxicity.

Purpose of the Study:

• To review the current research on IGF1-R as a therapeutic target in head and neck cancer.
• To explore the potential of microRNAs (miRNAs) as a novel biologic therapy.
• To highlight the combined therapeutic potential of targeting IGF1-R and its downstream signaling via miRNAs.

Main Methods:

• Literature review of current research on IGF1-R targeted therapy.
• Analysis of studies investigating the role of miRNAs in head and neck cancer.
• Synthesis of findings on the interplay between IGF1-R signaling and miRNA regulation.

Main Results:

• IGF1-R plays a significant role in head and neck tumor development, progression, and metastasis.
• Current IGF1R-targeted therapies show promise but are limited by acquired resistance and side effects.
• miRNAs are master regulators of gene expression and demonstrate potential as therapeutic agents.

Conclusions:

• There is a critical need for novel therapeutic strategies beyond direct IGF1-R targeting.
• miRNAs represent a promising avenue for biologic therapy in head and neck cancer.
• Targeting downstream signaling pathways modulated by miRNAs could overcome limitations of current treatments.